AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2021

Feb 18, 2021

30198_dirs_2021-02-17_70bef586-5a99-4cab-ab02-dabbfc751405.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-02-16

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-16	Common Stock	S	1875	$412.03	Disposed	10092	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	806	Direct

Footnotes

F1: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.